CMV-SpyCas9 Citations (4)

Originally described in: Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9.
Bubeck F, Hoffmann MD, Harteveld Z, Aschenbrenner S, Bietz A, Waldhauer MC, Borner K, Fakhiri J, Schmelas C, Dietz L, Grimm D, Correia BE, Eils R, Niopek D Nat Methods. 2018 Oct 30. pii: 10.1038/s41592-018-0178-9. doi: 10.1038/s41592-018-0178-9. PubMed Journal

Articles Citing CMV-SpyCas9

Articles
Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins. Hoffmann MD, Aschenbrenner S, Grosse S, Rapti K, Domenger C, Fakhiri J, Mastel M, Borner K, Eils R, Grimm D, Niopek D. Nucleic Acids Res. 2019 Apr 15. pii: 5458120. doi: 10.1093/nar/gkz271. PubMed Associated Plasmids AAV N-SpyCas9-Intein, U6-gRNA scaffold (F+E) AAV Intein-C-SpyCas9, CMV-AcrIIA4-scaffold (2xBsmBI sites) AAV Intein-C-SpyCas9, CMV-AcrIIA4-2xmiR-122 target sites pAAV-RSV-GFP-U6-Rosa26 gRNA (SpyCas9 scaffold) AAV CMV-driven AcrIIA4-scaffold (2xBsmBI sites) More ...
A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins. Gama-Brambila RA, Chen J, Dabiri Y, Tascher G, Nemec V, Munch C, Song G, Knapp S, Cheng X. JACS Au. 2021 May 12;1(6):777-785. doi: 10.1021/jacsau.1c00007. eCollection 2021 Jun 28. PubMed Associated Plasmids Cas9-FCPF
A deep mutational scanning platform to characterize the fitness landscape of anti-CRISPR proteins. Stadelmann T, Heid D, Jendrusch M, Mathony J, Aschenbrenner S, Rosset S, Correia BE, Niopek D. Nucleic Acids Res. 2024 Dec 11;52(22):e103. doi: 10.1093/nar/gkae1052. PubMed
In Vivo Prime Editing by Lipid Nanoparticle Co-delivery of Chemically Modified pegRNA and Prime Editor mRNA. Chen Z, Kelly K, Cheng H, Dong X, Hedger AK, Li L, Sontheimer EJ, Watts JK. GEN Biotechnol. 2023 Dec;2(6):490-502. doi: 10.1089/genbio.2023.0045. Epub 2023 Dec 15. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.